Johnson & Johnson (JNJ) Financials

JNJ Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 ? ?
March 31, 2026 200.9 billion 119.7 billion
Dec. 31, 2025 199.2 billion 117.7 billion
Sept. 30, 2025 192.8 billion 113.5 billion

JNJ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 1.5 billion 300.0 million
Dec. 31, 2025 5.5 billion 309.0 million
Sept. 30, 2025 8.4 billion 347.0 million

JNJ Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 ?
March 31, 2026 5.2 billion
Dec. 31, 2025 5.1 billion
Sept. 30, 2025 5.2 billion

JNJ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 - - -
March 31, 2026 22.1 billion 37.5 billion -
Dec. 31, 2025 20.1 billion 39.4 billion -
Sept. 30, 2025 18.6 billion 39.4 billion -

JNJ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.4 billion
March 31, 2026 2.4 billion
Dec. 31, 2025 2.4 billion
Sept. 30, 2025 2.4 billion

JNJ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3.7 billion 6.4 billion -
March 31, 2026 1.0 billion 3.5 billion 6.0 billion -
Dec. 31, 2025 1.8 billion 4.3 billion 6.8 billion -
Sept. 30, 2025 788.0 million 3.7 billion 5.9 billion -

JNJ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 25.3 billion 6.8 billion
March 31, 2026 24.1 billion 6.9 billion
Dec. 31, 2025 24.6 billion 8.0 billion
Sept. 30, 2025 24.0 billion 7.3 billion

JNJ Revenue by Segment
Graph available only for paid members. Upgrade to see it.

JNJ

List: Champions

Price: $260.35

52 week price:
170.39
274.90

Dividend Yield: 2.04%

5-year range yield:
2.03%
3.37%

Forward Dividend Yield: 2.06%

Payout Ratio: 75.04%

Payout Ratio Range:
-4326.47%
713.30%

Dividend Per Share: 5.36 USD

Earnings Per Share: 8.67 USD

P/E Ratio: 28.91

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 6.9 million

Ebitda: 2.9 billion

Market Capitalization: 618.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 26

DGR3: 5.07%

DGR5: 5.32%

DGR10: 5.77%

DGR20: 7.38%

Links: